Literature DB >> 18843101

Frequency of apolipoprotein E4 among older compared with younger HIV patients: support for detrimental effect of E4 on survival.

Victor Valcour, Bruce Shiramizu, Cecilia Shikuma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18843101      PMCID： PMC2572910          DOI： 10.1073/pnas.0806919105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  3 in total

1.  Circulating proviral HIV DNA and HIV-associated dementia.

Authors:  Bruce Shiramizu; Suzanne Gartner; Andrew Williams; Cecilia Shikuma; Silvia Ratto-Kim; Michael Watters; Joleen Aguon; Victor Valcour
Journal:  AIDS       Date:  2005-01-03       Impact factor: 4.177

2.  Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort.

Authors:  V Valcour; C Shikuma; B Shiramizu; M Watters; P Poff; O A Selnes; J Grove; Y Liu; K-B Abdul-Majid; S Gartner; N Sacktor
Journal:  J Neuroimmunol       Date:  2004-12       Impact factor: 3.478

3.  Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression.

Authors:  Trevor D Burt; Brian K Agan; Vincent C Marconi; Weijing He; Hemant Kulkarni; Jeffrey E Mold; Marielle Cavrois; Yadong Huang; Robert W Mahley; Matthew J Dolan; Joseph M McCune; Sunil K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205
  3 in total
  11 in total

1.  Genetic testing and HIV dementia: teasing out the molecular mechanisms of disease.

Authors:  Jay Rappaport; Joseph R Berger
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

2.  No association between Apoε4 alleles, HIV infection, age, neuropsychological outcome, or death.

Authors:  James T Becker; Jeremy J Martinson; Sudhir Penugonda; Lawrence Kingsley; Samantha Molsberry; Sandra Reynolds; Aaron Aronow; Karl Goodkin; Andrew Levine; Eileen Martin; Eric N Miller; Cynthia A Munro; Ann Ragin; Ned Sacktor
Journal:  J Neurovirol       Date:  2014-11-12       Impact factor: 2.643

3.  Translational research in NeuroAIDS: a neuroimmune pharmacology-related course.

Authors:  Amanda Brown; Bruce Shiramizu; Avindra Nath; Valerie Wojna
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-25       Impact factor: 4.147

4.  Association between apolipoprotein E4 genotype and human immunodeficiency virus-associated dementia in younger adults starting antiretroviral therapy in South Africa.

Authors:  John A Joska; Marc Combrinck; Victor G Valcour; Jacqueline Hoare; Felicity Leisegang; Anna Cecilia Mahne; Landon Myer; Dan J Stein
Journal:  J Neurovirol       Date:  2010-10       Impact factor: 2.643

5.  Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.

Authors:  Jacqueline Rosenthal; William Tyor
Journal:  J Neurovirol       Date:  2019-03-13       Impact factor: 2.643

Review 6.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

7.  Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity.

Authors:  Stella E Panos; Charles H Hinkin; Elyse J Singer; April D Thames; Sapna M Patel; Janet S Sinsheimer; A C Del Re; Benjamin B Gelman; Susan Morgello; David J Moore; Andrew J Levine
Journal:  Neurobehav HIV Med       Date:  2013-06-19

8.  Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders.

Authors:  E E Morgan; S P Woods; S L Letendre; D R Franklin; C Bloss; A Goate; R K Heaton; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; J A McCutchan; R J Ellis; I Abramson; A Gamst; C Fennema-Notestine; D M Smith; I Grant; F Vaida; D B Clifford
Journal:  J Neurovirol       Date:  2013-02-14       Impact factor: 2.643

Review 9.  Neurodegeneration and ageing in the HAART era.

Authors:  Bruce J Brew; S M Crowe; A Landay; Lucette A Cysique; Gilles Guillemin
Journal:  J Neuroimmune Pharmacol       Date:  2008-12-06       Impact factor: 4.147

Review 10.  Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review.

Authors:  Inga Kuhlmann; Anne Marie Minihane; Patricia Huebbe; Almut Nebel; Gerald Rimbach
Journal:  Lipids Health Dis       Date:  2010-01-28       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.